VRDN · US market
Viridian Therapeutics, Inc.
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$2.15bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$386.97m
- Latest-quarter run-rate earnings
- -US$508.48m
- Latest fiscal-year earnings
- -US$342.60m
- Trailing revenue
- US$71.13m
- Latest-quarter run-rate revenue
- US$1.14m
- Latest fiscal-year revenue
- US$70.85m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- FMED · Fidelity Disruptive Medicine ETF1.34% weight · Holdings dated 31 May 2026
- XBI · State Street SPDR S&P Biotech ETF0.86% weight · Holdings dated 21 August 2026
- HGHAX · The Hartford Healthcare Fund Class A0.51% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- IWC · iShares Micro-Cap ETF0.50% weight · Holdings dated 21 August 2026
- SSCGX · SEI Institutional Managed Trust Small Cap Growth Fund Class F0.31% weight · Holdings dated 30 June 2026
- ORSIX · North Square Dynamic Small Cap Fund Class I0.29% weight · Holdings dated 31 May 2026
- QASCX · Federated Hermes MDT Small Cap Core Fund Class A0.24% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- QUAZX · AB Small Cap Growth Portfolio Class Z0.24% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- SLLAX · SEI Institutional Managed Trust Small Cap Fund Class F0.23% weight · Holdings dated 30 June 2026
- NMCAX · Voya MidCap Opportunities Fund Class A0.22% weight · Holdings dated 31 May 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.